Type 2 Diabetes Clinical Trial
Official title:
Exercise as a Tool for Studying the Mechanisms and Applicability of Glycemic Variability in Individuals With and Without Type 2 Diabetes Mellitus
The aim this study is characterize glycemic variability using linear and nonlinear mathematical tools, under basal conditions and in response to specific protocols acute exercise that evoke oxidative stress and inflammation in healthy subjects and type 2 diabetes patients. For this purpose, the sample size will consist of 37 individuals healthy and 32 without type 2 diabetes mellitus wore a CGMS during 3 days. Participants randomly performed aerobic and eccentric sessions, both in the morning (24h after CGMS placement), and at least 7 days apart. Glucose variability was evaluated by glucose standard deviation, glucose variance, mean amplitude of glycemic excursions (MAGE), and glucose coefficient of variation (conventional methods) as well as by spectral and symbolic analysis (non-conventional methods). Physiological mechanisms altered by exercise protocols (Human Soluble Interleukin-6 and Glutathione), will be measured in blood samples.
The aim this study is characterize glycemic variability using linear and nonlinear
mathematical tools, under basal conditions and in response to specific protocols acute
exercise that evoke oxidative stress and inflammation in healthy subjects and type 2
diabetes patients. For this purpose, the sample size will consist of 37 individuals healthy
and 32 without type 2 diabetes mellitus, which will undertake the two types of exercise,
randomly distributed. The maximal incremental exercise test will be performed in
electrically braked cycle ergometer (ER-900, Jaeger, Wu¨ rzburg, Germany) in order to assess
possible contraindications to the proposed protocol as well functional capacity, which will
be used in prescription of the aerobic exercise session and a testing strength maximal will
be conducted and used in the prescription of the eccentric exercise session.
The glucose variability will be assessed by continuous glucose monitoring system (CGMS)
during 72h. Glucose variability will be evaluated by glucose standard deviation, glucose
variance, mean amplitude of glycemic excursions (MAGE), and glucose coefficient of variation
(conventional methods) as well as by spectral and symbolic analysis (non-conventional
methods). Physiological mechanisms altered by exercise protocols will be measured in blood
samples., Human Soluble Interleukin-6 ( HU IL 6 ELISA KIT - BIOSOURCE) and Glutathione (GSH)
indicator of oxidative stress (GSH assay in: Rahman I, Kode A, Biswas SK. Nat Protoc.
2006;1(6):3159-65). The aerobic session will consist of 40 min of lower limb bicycle at 70%
of the peak heart rate, as determined in the incremental exercise test and eccentric session
will consist of 40 min of one lower -limb exercises (leg press) with 6 sets of 10
repetitions at 120% of 1-RM. The protocol was approved by the Ethics in Research Committee
at Hospital de Clínicas de Porto Alegre and all patients will provide their written informed
consent before the participation.The research will be performed at the Exercise
Pathophysiology Research laboratory of the Hospital de Clínicas de Porto Alegre. We believe
that signs of glycemic variability has characteristics detectable by alternative, related to
hysiological processes such as oxidative stress and inflammation, evoked by aerobic and
eccentric exercise protocols mathematical methods, may help explain the acute response of
healthy individuals and patients with type 2 diabetes.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05219994 -
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
|
N/A | |
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Completed |
NCT02284893 -
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
|
Phase 3 | |
| Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
| Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
| Active, not recruiting |
NCT05566847 -
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Completed |
NCT04965506 -
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
|
Phase 2 | |
| Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
| Active, not recruiting |
NCT03982381 -
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
|
Phase 4 | |
| Completed |
NCT04971317 -
The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages
|
N/A | |
| Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
| Completed |
NCT04023539 -
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
| Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
| Completed |
NCT04097600 -
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
|
Phase 1 | |
| Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
| Completed |
NCT05378282 -
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
|
||
| Active, not recruiting |
NCT06010004 -
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT03653091 -
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
|
N/A |